Sarah Daugherty, PhD, MPH, served as a Senior Program Officer in the Clinical Effectiveness and Decision Science program at the Patient-Centered Outcomes Research Institute (PCORI) from October 2013 until August 2020. In this role, she provided oversight for several large pragmatic clinical trials, and manages a diverse cancer research and methods portfolio focused on comparative effectiveness and patient-centered outcomes.
Before joining PCORI, Daugherty was at the National Cancer Institute, where she initiated, designed, and led a multicenter follow-up study of men diagnosed with prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. This study was designed to identify biomarkers and prognostic factors that are associated with prostate cancer progression. She has conducted both quantitative and qualitative research projects, published papers on etiologic factors related to cancer outcomes, and served as a visiting professor of epidemiology at Georgetown University and the University of Baltimore. Daugherty is particularly interested in identifying multilevel factors that contribute to decision making across the healthcare continuum.
Daugherty received a BA in biology from Carleton College, a dual MPH in health behavior and health education and epidemiology from the University of Michigan, and a PhD in genetic epidemiology from the Johns Hopkins Bloomberg School of Public Health.